WESCOTT PHARMA - Masteron Propionate

Drostonalone propionate is an androgen and anabolic steroid, it is used for palliation of androgen-responsive recurrent breast cancer in women who are more than one year but less than five years postmenopausal.

Drostanolone propionate causes a decrease or inhibition of prolactin or estrogen receptors in the breasts, which is linked to its antitumor effect. It also interacts with the androgen receptor and activates a cascade of genetic changes, including increased protein synthesis (anabolism) and decreased amino acid degradation (catabolism).

• An allergy or hypersensitivity to the drostanolone propionate or to any other component of this drug.
  
  
• Breast cancer in males.
  
  
• Known or suspected prostate cancer.
  
  
• Pregnancy – confirmed or planned.
  
  
• Serious cardiac disease.
  
  
• Chronic hepatic or renal diseases.

Dosage and side effects

This drug is administered only intramuscularly. The recommended dose is 1,4 mg/kg of body weight 3 times a week.

Like all medicines, Drostonalone propionate can cause side effects. The drug has no estrogenic effects.

The following side effects (frequency data not available) were observed during the treatment:

In women: the appearance of irreversible signs of virilization (see Precautions).

In men: baldness, increased body hair growth, acne, suppression own testosterone production, which leads to a decrease in muscle volume and strength, decreased libido, erectile dysfunction, and increased irritability. In both sexes: hypercalcemia, increased bad cholesterol levels, a significant reduction of good cholesterol levels